Artificial hip and knee maker Smith & Nephew has appointed Namal Nawana to replace Olivier Bohuon as chief executive of the British company next month.
Mr Nawana was most recently chief executive of medical diagnostics company Alere, where he oversaw its £3.7bn acquisition by Abbott in 2017, Smith & Nephew said.
He will take over from Bohuon, who said in October he would leave before the end of 2018, on May 7. His base salary will be $1.54m a year, the company said.
Mr Nawana said: “I am passionate about the medical devices industry where I have worked all my life and it is an honour to become the new Chief Executive of Smith & Nephew, a company I greatly admire.
“I am most excited by its portfolio of innovation which I believe gives an excellent platform from which to drive the business forward into its next exciting chapter.”
Roberto Quarta, chairman of Smith & Nephew, said: “In Namal I am delighted that we have secured an exceptional new chief executive with a proven record within the medical device industry.
“He has the experience as a CEO of a major listed company in the healthcare sector, and has demonstrated that he can energise businesses to deliver better performance and greater value to shareholders.
“We are looking forward to him joining our Board and driving Smith & Nephew to the next level of success.”
Smith & Nephew was founded in East Yorkshire and is a major emloyed in the region.